Tarrant, Texas (TX) In Vitro and In Vivo Diagnostic Substances Companies

Featured companies
Sleep Solutions Inc
2119 Grenoble Dr APT 241
Arlington TX 76006
(682) 597-3425
Hrc Biotek Inc
1116 West Pioneer Parkway
Arlington TX 76013
(817) 795-6001
Qit
1734 Martel Ave.
Fort Worth TX 76103
(817) 535-4647
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Catholics Respect Life
800 West Loop 820 South
Fort Worth TX 76108
Cardinal Health 414 LLC
14801 Sovereign Road
Fort Worth TX 76155
(817) 358-6989
The Fourth Trimester Services
3301 Hamilton Avenue # 111
Fort Worth TX 76107
(214) 794-1364
Bracco Diagnostics Inc
1400 W NW Hwy Ste 240
Grapevine TX 76051
(817) 329-1696
Bracco Diagnostics Inc
1400 West Northwest Highway # 240
Grapevine TX 76051
(817) 329-1696
The Center for Assisted Reproduction
1701 Park Place Avenue
Bedford TX 76022
(866) 284-5289

The Center for Assisted Reproduction (CARE Fertility) was established in 1989. Our mission is to provide comprehensive medical care for the treatment
Whereorg has 15 results under In Vitro and In Vivo Diagnostic Substances Companies in Tarrant.

Narrow down the browsing criteria below to see more companies.

Select a location for category In Vitro and In Vivo Diagnostic Substances


Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020